UDP-GalNAc : GalNAc-mucin α-N-acetylgalactosamine transferase activity in human intestinal cancerous tissues  by Kurosaka, Akira et al.
Volume 190, number 2 FEBS 2967 October 1985 
UDP-GalNAc : GalNAc-mucin a-IV-acetylgalactosamine 
transferase activity in human intestinal cancerous tissues 
Akira Kurosaka, Ikuo Funakoshi, Mutsushi Matsuyama+, Takeo Nagayo+ and Ikuo Yamashina* 
Department of Biological Chemistry, Faculty of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto 606 and 
+Aichi Cancer Research Institute, Nagoya, Aichi 464, Japan 
Received 15 August 1985 
GalNAc transferase activities of 6 human intestinal cancerous tissues were examined using bovine submaxil- 
lary gland mucin and its desialylated derivative, asialomucin, as acceptors. A Triton X-100 extract of these 
tissues was used as an enzyme source. All the tissues examined had GalNAc transferase that catalyzes the 
transfer of GalNAc from UDP-GalNAc to serine or threonine residues of the polypeptide chain. One of 
6 specimens showed in addition UDP-GalNAc:GalNAc-mucin a-GalNAc transferase activity, synthesizing 
a disaccharide unit, GalNAca+GalNAc, when asialomucin was used as an acceptor. This carbohydrate 
structure was deduced on the basis of results of gel filtration, exoglycosidase digestion. and high-voltage 
paper electrophoresis. 
GalNAc transferase Human intestinal cancerous tissue Bovine submaxillary gland mucin 
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1. INTRODUCTION 
The carbohydrate moieties of mucins are often 
altered on malignant transformation of cells [l-3]. 
The alterations should be ascribed to the changes 
in activities of glycosyltransferases and/or 
glycosidases that are responsible for the biosyn- 
thesis or degradation of the sugar units of such 
glycoproteins [2]. 
In our previous reports [4,5], the structures of 
the major sugar units of the mucins produced by a 
human rectal adenocarcinoma were determined 
including a novel structure, SiacY2+6(Gal- 
NAccv1+3)GalNAcol. To search for the GalNAc 
transferase that should be involved in the biosyn- 
thesis of this sugar chain, 6 human intestinal can- 
cerous tissues were examined with respect to their 
GalNAc transferase activities using bovine sub- 
maxillary gland mucin and its desialylated deriva- 
tive, asialomucin, as acceptors. Here we report the 
occurrence of an a-GalNAc transferase in one of 
the tissues that transfers [1-14C]GalNAc from 
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UDP-[ l-i4C]GalNAc to asialomucin (its major 
sugar unit: GalNAc+Ser(Thr)) to produce disac- 
charide, [l-‘4C]GalNA~-+GalNAc(+Ser or Thr), 
indicating that this enzyme may be responsible for 
the biosynthesis of the above unique oligosac- 
charide. 
2. MATERIALS AND METHODS 
2.1. Materials 
UDP-[1-14C]GalNAc (54 mCi/mmol) was pur- 
chased from the Radiochemical Centre, Amer- 
sham. UDP-GalNAc was a generous gift from 
Professor S. Suzuki of Nagoya University. N- 
Acetylgalactosaminitol was prepared in our 
laboratory by conventional procedures. Gal- 
NAm1+3GalNAcol was prepared from a human 
rectal adenocarcinoma glycoprotein [5]. Sephadex 
G-50 (fine) and Sephadex G-25 (superfine) were 
obtained from Pharmacia, Uppsala, and AG 
5OWX8 (H+ form, 200-400 mesh) was from Bio- 
Rad, Richmond. u-N-Acetylgalactosaminidase 
from Charonia lampas was purchased from 
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Seikagaku Kogy, Tokyo. Human intestinal can- 
cerous tissues were dissected free from all sur- 
rounding normal tissues and stored at - 80°C 
before use. 
2.2. Preparation of acceptors 
The major mucin was prepared from bovine 
submaxillary glands as described [6]. Asialomucin 
was prepared from the major mucin by mild acid 
hydrolysis (0.05 M H2S04, 8O”C, 1 h). 
2.3. Preparation of enzyme source 
A portion of each tumor tissue was minced and 
homogenized with a Potter-Elvehjem type 
homogenizer in 0.1 M imidazole/HCl buffer, pH 
7.2. Triton X-100 was added to the homogenate to 
1 %, and proteins were extracted with constant stir- 
ring for 1 h at 0°C. The solution was centrifuged 
at 10000 x g for 20 min. The supernatant obtained 
was used as an enzyme source. 
2.4. Assay of GalNAc transferase and 
characterization of the reaction products 
Incubation mixtures contained the following 
components in a final volume of 800~1: enzyme 
proteins (-3 mg protein), 4rmol BAL 
(2,3-dimercapto-1-propanol), 0.08 prnol ATP, 
40rmol imidazole/HCl buffer, pH 7.2, 8 pmol 
MnClz, 3 mg Triton X-100, acceptor proteins 
(6 mg mucin or 4 mg asialomucin), and 120 nmol 
UDP-[l-14C]GalNAc (10000 dpm/nmol). 
After incubation of the reaction mixture at 37°C 
for 2 h with a few drops of toluene, the reaction 
was terminated by adding 100~1 of 0.5 M EDTA. 
Insoluble materials formed during the incubation 
were removed by centrifugation at 105400 x g for 
30 min. The supernatant was concentrated to a 
small volume by a rotary evaporator and then ap- 
plied to a column of Sephadex G-50 (fine, 1.0 x 
94 cm) developed with 0.2 M NaCl. Radioactive 
products in the void fraction that contained accep- 
tor proteins were separated from the radioactive 
low-M, materials derived from 14C-labeled sugar 
nucleotides and their degradation products. The 
void fraction was dialyzed against water and 
lyophilized. The lyophilized materials were sub- 
jected to alkaline borohydride degradation as in 
[4], and the released oligosaccharides were applied 
to a column of Sephadex G-25 (superfine, 1.8 x 
260 
180 cm) developed with 0.05 M pyridine/acetic 
acid buffer, pH 5.0. 
2.5. Analytical methods 
Protein was determined by the method of Lowry 
et al. [7] with bovine serum albumin as the stan- 
dard. High-voltage paper electrophoresis was per- 
formed on Toyo no.SlA paper using 0.06 M 
borate buffer, pH 9.5, at 35 V/cm for 4 h [8]. 
Sugar standards were localized on paper with 
alkaline silver nitrate reagent after treatment with 
periodate. Radioactivity was determined by liquid 
scintillation counting. The digestion of oligosac- 
charides with cu-N-acetylgalactosaminidase was 
carried out as in [5]. 
3. RESULTS AND DISCUSSION 
We recently reported the structures of the major 
oligosaccharides isolated from a human rectal 
adenocarcinoma, including a novel trisaccharide, 
Sim2-,6(GalNAccu1+3)GalNAcol [5]. In addi- 
tion, isolation of oligosaccharide chains containing 
the GalNAccvld3GalNAcol structure has been 
reported from a few laboratories [g-12]. To 
characterize the GalNAc transferase involved in 
the biosynthesis of this unique structure, 6 human 
cancerous tissues have been examined for 
transferase activities. For the incubation, it was 
essential to use BAL and ATP as inhibitors of 
nucleotide pyrophosphatase which degrades ugar 
nucleotides [ 131. 
The acceptors to which [l-14C]GalNAc was 
transferred were recovered by gel filtration on 
Sephadex G-50, and successively applied to a col- 
umn of Sephadex G-25 after reductive cleavage of 
0-glycosidically linked sugar chains. Five out of 6 
cancerous tissues showed the same elution profile 
on Sephadex G-25 chromatography (not shown). 
The only discernible radioactive peaks appeared at 
the elution position corresponding to that of 
GalNAcol. These facts suggested the presence of 
GalNAc transferase in these tissues that catalyzed 
the transfer of GalNAc from UDP-GalNAc to 
serine or threonine residues of the polypeptide 
chain. 
One of the tissues gave a quite different elution 
profile on the same gel filtration (fig.1). In addi- 
tion to a peak which corresponded to GalNAcol, 
several peaks could be seen when mucin or 
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Fig. 1. Sephadex G-25 column chromatography of the 
asialomucin added as an acceptor. 
oligosaccharides of the reaction products of one of the 
6 tissues. Arrows indicate the positions of the standard 
sugars: (1) GalNAccYl+3GalNAcol, (2) GalNAcol. (a) 
No acceptor added, (b) mucin added as an acceptor, (c) 
asialomucin was used as an acceptor. The peaks at 
tube no.llO-130 appeared to be produced by the 
transfer of GalNAc to complex carbohydrate 
chains of acceptor glycoproteins. The occurrence 
of such complex carbohydrate chains besides the 
major disaccharide, NeuAm2+6GalNAc, in 
bovine submaxillary gland mucin has been 
reported by Herp et al. [14] inter alia. This also 
raised the possibility that multiple GalNAc 
transferase activities were enhanced in this tissue. 
Of these oligosaccharide chains, fraction A eluted 
at the same position as GalNAccvl*3GalNAcol, 
was produced only when asialomucin was used as 
an acceptor. 
To investigate the carbohydrate structure of 
fraction A (its homogeneity was checked by high- 
voltage paper electrophoresis as shown in fig.2), 
its aliquot was digested with c&Cacetylgalactos- 
aminidase and the digest was applied to the same 
Sephadex G-25 column. The elution position of the 
radioactivity shifted to that corresponding to that 
of GalNAc or GalNAcol, suggesting the release of 
GalNAc upon the enzymatic digestion. The release 
of GalNAc was further confirmed by high-voltage 
paper electrophoresis that is capable of separating 
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Fig.2. High-voltage paper electrophoresis of fraction A 
before and after cY-N-acetylgalactosaminidase digestion. 
Electrophoresis was carried out as described insection 2. 
Migration was toward the anode (left to right). The 
paper was cut into 1.0 cm wide segments that were 
extracted with 0.6 ml distilled water and radioactivities 
of the extracts were determined. Arrows indicate the 
positions of the standard sugars: (1) GalNAc, (2) 
GalNAcol. (a) cu-N-Acetylgalactosaminidase igest of 
GalNAc and GalNAcol from each other (fig.2). 
After digestion, the position of the radioactive 
peak shifted to that of GalNAc, confirming the 
release of a-linked GalNAc on cr-N-acetylgalactos- 
aminidase digestion. Thus, fraction A was iden- 
tified as GalNAw+GalNAcol. It is therefore ap- 
parent that in this tissue GalNAc transferase is pres- 
ent which transfers GalNAc in the a-configura- 
tion to GalNAc attached to the polypeptide chain. 
This enzyme is distinct from UDP-Gal- 
NAc: polypeptide GalNAc transferase since 5 out 
of 6 tissues that have the latter enzyme activity can- 
not produce the GalNAti+GalNAc sequence 
from asialomucin used as an acceptor. This is also 
consistent with the results of specificity studies on 
the purified UDP-GalNAc : polypeptide GalNAc 
transferase [6]. Other a-GalNAc transferases 
which have been investigated in detail are UDP- 
GalNAc : globoside mu-GalNAc transferase and A 
blood group specific GalNAc transferase [15,161. 
The former enzyme, that produces Forssman an- 
tigen, was purified from canine spleen [ 151. We 
prepared a Triton X-100 extract of canine spleen, 
but the extract did not generate the disaccharide 
(GalNAccu-rGalNAcol). Thus, this enzyme is not 
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responsible for the biosynthesis of Gal- 
NAccv+GalNAc-+polypeptide. The activity of A 
blood group specific GalNAc transferase, assayed 
using lact-N-fucopentaose I as an acceptor, was 
detected in the tissue extract in which the present 
new GalNAc transferase activity was detected. 
However, the GalNAc transfer to lact-N- 
fucopentaose I was not inhibited by asialomucin 
indicating that these two transferases are different. 
Although the assignment of the position of 
GalNAc attachment o GalNAcol was not carried 
out owing to the limited amounts of the material, 
it is possible that this disaccharide may be a precur- 
sor of the trisaccharide, Siti2+6(GalNAc- 
al +3)GalNAcol. 
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